Cover Image

A prospective cohort study protocol: monitoring and surveillance of adverse events following heterologous booster doses of Oxford AstraZeneca COVID-19 vaccine in previous recipients of two doses of Sinopharm or Sputnik V vaccines in Iran

Abstract Background Regarding the paucity of evidence on the side effects of the booster dose of Oxford AstraZeneca vaccine in vaccinated people with Sinopharm or Sputnik V, we aimed to set up a cohort event monitoring (CEM) study to capture adverse events occurring in individuals who will receive t...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shahin Soltani (Author), Behzad Karami Matin (Author), Mohammad Mehdi Gouya (Author), Sayed Mohsen Zahraei (Author), Ghobad Moradi (Author), Omid Chehri (Author), Moslem Soofi (Author), Mehdi Moradinazar (Author), Fatemeh Khosravi Shadmani (Author), Mahsa Kalantari (Author), Hamidreza Khajeha (Author), Mohammad Hassan Emamian (Author), Farid Najafi (Author)
Format:	Book
Published:	BMC, 2023-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Lipschütz ulcers after AstraZeneca COVID-19 vaccination
by: Maria Bracho-Borro, et al.
Published: (2023)

Busting the Breast Cancer with AstraZeneca's Gefitinib
by: S. Chemmalar, et al.
Published: (2023)

New-onset bullous pemphigoid triggered by AstraZeneca COVID-19 vaccine
by: Yin-Cheng Chao, et al.
Published: (2022)

[Translated article] Lipschütz Ulcers After the AstraZeneca COVID-19 Vaccine
by: N. González-Romero, et al.
Published: (2022)

Zoster infection after vaccination with the AstraZeneca COVID-19 vaccine: A case report
by: Laurent Dupoirieux
Published: (2022)

Side Effects Following Administration of the First Dose of Oxford-AstraZeneca's Covishield Vaccine in Bangladesh: A Cross-Sectional Study
by: Nishat Jahan, et al.
Published: (2021)

A case of acute transverse myelitis following the AstraZeneca COVID-19 vaccine
by: Reema Madike, et al.
Published: (2023)

A case of pityriasis rubra pilaris following AstraZeneca COVID-19 vaccine
by: Miki Wada, BMedSc, MD, et al.
Published: (2022)

Acquired Thrombotic Thrombocytopenic Purpura after AstraZeneca Vaccine: a Case Report
by: Fatemeh Yaghoobi, et al.
Published: (2022)

Drug reaction with eosinophilia and systemic symptoms syndrome following vaccination with the AstraZeneca COVID-19 vaccine
by: Thomas O'Connor, et al.
Published: (2022)

Cutaneous lupus erythematosus flare with vitiligo-like depigmentation following the AstraZeneca COVID vaccine
by: Farrah Bakr, MBBS, MRCP, et al.
Published: (2022)

Rhabdomyolysis following Oxford/AstraZeneca COVID-19 vaccination; two case reports from Iran
by: Marzieh Hashemi, et al.
Published: (2024)

Radiation recall dermatitis triggered by the AstraZeneca COVID-19 vaccine: A case report and literature review
by: Ya-Wen Tsai, et al.
Published: (2022)

Infographics on risks associated with COVID-19 and the willingness to get the AstraZeneca vaccine: two randomized online experiments
by: Lisa Felgendreff, et al.
Published: (2024)

Psoriatic flare following Oxford-AstraZeneca ChAdOx1 COVID-19 and influenza vaccines
by: Natalie Teh, et al.
Published: (2021)

Autoimmune Hepatitis after AstraZeneca Coronavirus Disease 2019 (COVID-19) vaccine: need for epidemiological study
by: Sofia Bizarro Ponte, et al.
Published: (2022)

Gender disparities and associated factors to intention to getting a second dose of COVID-19 AstraZeneca vaccine among adult populations in selected facilities of Lusaka, Zambia.
by: Choolwe Jacobs, et al.
Published: (2022)

Gender disparities and associated factors to intention to getting a second dose of COVID-19 AstraZeneca vaccine among adult populations in selected facilities of Lusaka, Zambia
by: Choolwe Jacobs, et al.
Published: (2022)

How (not) to mobilize health workers in the fight against vaccine hesitancy: Experimental evidence from Germany's AstraZeneca controversy
by: Jan Priebe, et al.
Published: (2022)

Vaccine efficacy against SARS-CoV-2 for Pfizer BioNTech, Moderna, and AstraZeneca vaccines: a systematic review
by: Lia Reynolds, et al.
Published: (2023)

Vaccine-associated complications: a comparative multicenter evaluation among dental practitioners and dental students-which candidate vaccine is more safe in SARS COV II, Gam-COVID-Vac (Sputnik V), ChAdOx1 nCoV-19 (AstraZeneca), BBV152 (Covaxin), or BBIBP-CorV(Sinopharm)?
by: Behzad Houshmand, et al.
Published: (2022)

Astra zeneca Covid vaccination conversion reaction
by: Roy G Beran
Published: (2021)

A report of stable segmental vitiligo with exacerbations following Oxford-AstraZeneca and MVC-COV1901 COVID-19 vaccinations
by: Tsung-Fu Tsai, et al.
Published: (2022)

A study of SARS-CoV-2 delta variant breakthrough infections and side effects of the Oxford-AstraZeneca vaccine
by: Nawfal R. Hussein, et al.
Published: (2022)

Technological order and technology transfer of the vaccine for COVID-19 in Brazil: a case study of the model used by AstraZeneca/Oxford and Fiocruz
by: Silvania lacovino Dantas, et al.
Published: (2022)

The knowledge, attitudes, and perceptions toward the Oxford AstraZeneca COVID-19 vaccine amongst Primary Health care workers in North-Central Trinidad
by: Raveed Khan, et al.
Published: (2023)

SARS‑CoV‑2 IgG antibody status in unvaccinated and 2‑dose vaccinated Indonesians by Astra Zeneca
by: Laura Yamani, et al.
Published: (2023)

The Effectiveness of Pfizer-BioNTech and Oxford-AstraZeneca Vaccines to Prevent Severe COVID-19 in Costa Rica: Nationwide, Ecological Study of Hospitalization Prevalence
by: Luis Rosero-Bixby
Published: (2022)

Self-reported side effects of the Oxford AstraZeneca COVID-19 vaccine among healthcare workers in Ethiopia, Africa: A cross-sectional study
by: Elias Ali Yesuf, et al.
Published: (2022)

Úlceras de Lipschütz tras la vacuna frente a la COVID-19 de AstraZeneca
by: N. González-Romero, et al.
Published: (2022)

Factors associated with initial AstraZeneca vaccine knowledge, attitudes, and uptake among hospital nurses: A cross-sectional study in Ghana's Upper East region.
by: Simon Ferguson Atongu, et al.
Published: (2024)

Evaluation and comparison of post-vaccination adverse effects among Janssen and Oxford-AstraZeneca vaccinated adult individuals in Debre Tabor Town: A cross- sectional survey in Northwest Ethiopia
by: Endeshaw Chekol Abebe, et al.
Published: (2022)

Utilization of health care services before and after media attention about fatal side effects of the AstraZeneca vaccine: a nation-wide register-based event study
by: Vilde Bergstad Larsen, et al.
Published: (2021)

Comparative immunogenicity and neutralizing antibody responses post heterologous vaccination with CoronaVac (Sinovac) and Vaxzevria (AstraZeneca) in HIV-infected patients with varying CD4+ T lymphocyte counts
by: Sorawit Chittrakarn, et al.
Published: (2024)

Effectiveness of AstraZeneca vaccine against SARS-CoV-2 (ChAdox1-S) in reducing in-hospital mortality in individuals with COVID-19 and schizophrenia: A retrospective cohort study
by: Tiffany Dyu, et al.
Published: (2024)

Pregnant and Breastfeeding Mothers Who Have Received the ChAdOx1 AstraZeneca COVID-19 Vaccine May Have Infants with an Increased Risk of Zinc Insufficiency and SCID Disease
by: Amr Ahmed, et al.
Published: (2023)

Thromboembolism after Astra Zeneca COVID-19 vaccine: Not always PF4- antibody mediated
by: Sascha d'Almeida, et al.
Published: (2023)

Humoral anti-SARS-CoV-2 immune response for different strains after Sinovac-CoronaVac and Oxford/AstraZeneca (ChAdOx1-S) full vaccination on a healthcare population in Brazil
by: Maicon Jeferson Silva de Oliveira, et al.
Published: (2024)

ANALISIS FRAMING PEMBERITAAN VAKSIN COVID-19 OXFORD-ASTRAZENECA DI INDONESIA(Studi Pada Pemberitaan Media Kompas.com & Tempo.co Tanggal 14 - 30 Juni 2021 Dalam Pemberitaan Vaksin Oxford-AstraZeneca)
by: Dian Rahmawati Subakti,
Published: (2022)

Efficacy of Sinopharm Vaccine Among Healthcare Workers of Pakistan
by: Faridah Amin, et al.
Published: (2024)